Low Dosage Hydrate Inhibitors Market - Forecast(2024 - 2030)
Low dosage hydrate inhibitors Market Overview
Low dosage hydrate inhibitors Market size is forecast to reach US$502.1 million by 2026, after growing at a CAGR of 7.4% during 2021-2026. Low-dosage hydrate
inhibitors are used in crude oil extraction procedures to reduce hydrate
accumulation in the systems, providing better flow assurance (fluid mechanics), decreasing the maintenance costs of crude
oil and gas extraction systems. The benefit of extending the lifespan of the
gas system by applying low-dosage hydrate inhibitors as oilfield chemicals
is projected to increase demand among crude oil product suppliers. Furthermore,
the possibility to manufacture combination products using
low-dosage hydrate inhibitors is boosting the demand even more. The
technologically advanced production process of low dosage hydrate inhibitors,
as well as ongoing research and development activities, are expected to influence
the low dosage hydrate inhibitors market in the coming years.
COVID-19 Impacts
The recent
COVID-19 epidemic, on the other hand, has had a major impact on the global Low
dosage hydrate inhibitors manufacturing industry. Production operations have
halted around the world in order to limit the spread of the coronavirus, which
has harmed production, but manufacturers are now back to normal.
Low dosage hydrate inhibitors Market Report Coverage
The report: “Low dosage hydrate inhibitors Market–
Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following
segments of the Low dosage hydrate inhibitors Industry.
By Product Type: Anti-Agglomerate (AA)
inhibitors, Kinetic Hydrate Inhibitors (KHI) (Polymers and Co-Polymers).
By Application: Onshore and Offshore.
By Geography: North America (USA, Canada, and Mexico),
Europe (the UK, Germany, France, Italy, Netherlands, Spain, Russia, Belgium and
the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia
and New Zealand, Indonesia, Taiwan, Malaysia and the Rest of Asia-Pacific), South America
(Brazil, Argentina, Colombia, Chile, and the Rest of South
America), the Rest of the World (the Middle East (Saudi Arabia, UAE, Israel, Rest
of the Middle East), and Africa (South Africa, Nigeria, and Rest of Africa)).
Key Takeaways
- North America led the market for Low dosage hydrate inhibitors, due to rising oil & gas production activities. For instance, according to the BP Statistical Review of World Energy 2020, the production of oil increased from 1042.2 million tonnes in 2018 to 1116.5 million tonnes in 2019, an increase of 7.1% in North America.
- Growing environmental concerns are driving the use of oilfield chemicals such as low-dose hydrate inhibitors.
- The low dosage hydrate inhibitors market is predicted to rise significantly in the near future, owing to the increasing demand from a recovering economy, increased industrial growth, and demand from the shale oil industry.
Figure: North America Low dosage hydrate inhibitors Market Revenue, 2020-2026 (US$ Million)
For More Details on This Report - Request for Sample
Low dosage hydrate inhibitors Market Segment Analysis – By Product Type
Anti-agglomerate
dominated the Low dosage hydrate inhibitors market in 2020 and is forecasted to
grow at a CAGR of 7.2% during the forecast period. This is due to the fact that
Anti-agglomerates provide significant benefits, such as cheaper capital costs, better
flow assurance (fluid mechanics), lower transportation costs, high
compatibility, and so on. Anti-agglomerate hydrate inhibitors are more
biodegradable oilfield chemicals than kinetic hydrate inhibitors, making them
the preferred choice for meeting environmental standards. As an effective
hydrate inhibitor type, Anti-agglomerate is widely pursued for diverse uses in
oil and gas fields. Anti-agglomerates are gaining popularity because they
successfully regulate and monitor hydrates to maintain flowline and pipeline
safety and integrity while lowering total costs in onshore and offshore
applications.
Low dosage hydrate inhibitors Market Segment Analysis – By End-Use Industry
The offshore segment
dominated the Low dosage hydrate inhibitors market in 2020 and is growing at a
CAGR of 7.7% during the forecast period 2021-2026, owning to falling temperature
points in several offshore oil fields and low dosage hydrate inhibitors ideal
application for blocking wax formation. In Indonesia, for instance, the Banyu
Urip refinery processes stabilized crude. This facility spends 20% of its
operating costs on PPDs on average. This is one of many offshore oil fields
that are becoming more popular around the world. The pipeline at the Urip field
is divided into two sections: a 72-kilometer onshore section and a 23-kilometer
offshore section. Because of the high wax content in Urip, the temperature in
the offshore section can drop as low as 24 degrees Celsius from its peak of 46
degrees. Low temperatures increase the risk of no-flow conditions, which can
cause significant damage due to pipeline blockages. Owning to which the low
dosage hydrate inhibitors are widely used in the offshore oilfield application.
Low dosage hydrate inhibitors Market Segment Analysis – By Geography
North America dominated the market with a share of 34% in 2020, owing to the increasing demand for oilfield chemicals such as low dosage hydrate inhibitors and due to the increasing shale gas exploration in the region in recent years. For instance, in 2019, the Canadian Association of Petroleum Producers (CAPP) stated that Canada is capable of producing 16,000 barrels of crude oil per day along with 5.5 billion cubic feet of natural gas per day. It also states that Canada's oil production is estimated to reach 106.3 million barrels per day by 2040. The government of the USA made an announcement to continue to operations of the Alaska LNG Liquefaction Plant project worth $43 billion in 2020. Furthermore, the Government of Canada has recently announced three offshore exploration drilling projects that will be operated by BHP, Equinor, and Chevron to progress in 2021. Therefore, an increase in oil and gas production activities also significantly increases the demand for low dosage hydrate inhibitors, thus, leading to market growth.
Low dosage hydrate inhibitors Market Drivers
Low-dose hydrate inhibitors are becoming more popular than thermodynamic inhibitors
Thermodynamic hydrate inhibitors have been used to combat gas
hydrate problems, particularly in the oil and gas industry. Thermodynamic
inhibitors have significantly higher logistical costs due to the massive
storage tanks and injection lines required in big quantities. Low-dose hydrate
inhibitors, on the other hand, are required in substantially less quantity and
are thus cited as cost-effective, transportation, storage, and efficient for
producers. Low-dose hydrates have been shown to be both cost-efficient and effective
hydrate treatment compounds, therefore their use will continue to grow over
traditional thermodynamic hydrate inhibitors.
Increasing Oil & Gas Sector
According to the BP Statistical Review of World Energy 2020, the
production of oil increased from 361.0 million tonnes in 2018 to 361.8 million
tonnes in 2019, an increase of 0.2% in the Asia Pacific. Furthermore, new
projects are under construction to sustain the increasing demand for oil and
gas. For instance, Eni S.p.A will begin the production of natural gas from its
Merakes offshore project in Indonesia by the end of 2021. Construction of
Tangguh Train 3 is progressing, with Indonesia's BP-operated LNG export
facility adding 3.8 MTPA of production capacity to the existing facility,
bringing the total capacity of the plant to 11.4 MTPA. In February 2019, the
progress of the National Strategic Project Development, namely the Cirebon
Power Unit 2, with a capacity of 1×1000 MW, has now reached 39 percent and is
targeted to operate in February 2022. Thus, with the flourishing oil and gas
sector, the demand for oilfield chemicals such as low dosage hydrate inhibitors
is also expected to increase as it provides improved flow assurance (fluid
mechanics), high compatibility, and so on.
Increasing Environmental Regulation Compliance
The oil and gas industry's growing emphasis on environmental
compliance is driving up demand for biodegradable materials. Because of their
low sustainability quotient, thermodynamic hydrate inhibitors have been pushed
aside in favor of more environmentally friendly options, such as low-dose
hydrate inhibitors. While manufacturers are always looking for new uses for
low-dose hydrate inhibitors, they are also increasing their efforts in product
innovation to meet the demands of sustainability which is influencing the low
dosage hydrate inhibitors market growth.
Low dosage hydrate inhibitors Market Challenges
Environmental issues caused by the use of anti-agglomerants (AA)
Hydrate inhibitors play a critical role in large commercial businesses like crude oil and natural gas production, making them a crucial component of the process. However, several hydrate inhibitor constraints are impeding the market's expansion. Anti-Agglomerants (AA) are crucial to utilize because they prevent hydrate inhibitor crystals from adhering together. However, it harms the ecosystem and consequently becomes a major constraint. Overuse of hydrate inhibitors during natural gas and crude oil production is strictly regulated since they have a negative impact on the environment. The hydrate inhibitor market is governed by a variety of laws and regulations, which are implemented at various phases of manufacture and distribution and the rules ensure the smooth workflow with no oilfield chemicals misuse.
Low dosage hydrate inhibitors Market Industry Outlook
Technology launches, acquisitions
and R&D activities are key strategies adopted by players in the Low dosage
hydrate inhibitors Market. The key players in the Low dosage hydrate inhibitors
Market includes
- Ashland Global Specialty Chemicals Inc.
- Halliburton
- Ecolab Inc.
- Baker Hughes Inc.
- Innospec Inc.
- JSC Gazprom Neftekhim Salavat
- BASF SE
- Evonik Industries AG
- Clariant AG
- Schlumberger Limited
Relevant Reports
Hydrate
Inhibitors Market - Forecast 2021 - 2026
Report Code: CMR 15263
Nitrification
and Urease Inhibitors Market - Forecast(2021 - 2026)
Report Code: CMR 1158
For more Chemicals and Materials Market reports, please click here
LIST OF TABLES
1.Global Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Product Type Market 2023-2030 ($M)1.1 By Product Type, Market 2023-2030 ($M) - Global Industry Research
2.Global Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Terrain Type Market 2023-2030 ($M)
2.1 By Terrain Type, Market 2023-2030 ($M) - Global Industry Research
3.Global Competition Analysis Market 2023-2030 ($M)
3.1 Competition Deep Dive Market 2023-2030 ($M) - Global Industry Research
3.1.1 BASF SE Market 2023-2030 ($M)
3.1.2 Schlumberger Market 2023-2030 ($M)
3.1.3 Arkema Group Market 2023-2030 ($M)
3.1.4 Ashland Market 2023-2030 ($M)
3.1.5 ERO CHEM LLC Market 2023-2030 ($M)
3.1.6 Halliburton Market 2023-2030 ($M)
3.1.7 Baker Hughes Incorporated Market 2023-2030 ($M)
3.1.8 Clariant Chemicals Market 2023-2030 ($M)
3.1.9 Ecolab Market 2023-2030 ($M)
3.1.10 GasHydrate LLC Market 2023-2030 ($M)
4.Global Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Product Type Market 2023-2030 (Volume/Units)
4.1 By Product Type, Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Terrain Type Market 2023-2030 (Volume/Units)
5.1 By Terrain Type, Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Competition Analysis Market 2023-2030 (Volume/Units)
6.1 Competition Deep Dive Market 2023-2030 (Volume/Units) - Global Industry Research
6.1.1 BASF SE Market 2023-2030 (Volume/Units)
6.1.2 Schlumberger Market 2023-2030 (Volume/Units)
6.1.3 Arkema Group Market 2023-2030 (Volume/Units)
6.1.4 Ashland Market 2023-2030 (Volume/Units)
6.1.5 ERO CHEM LLC Market 2023-2030 (Volume/Units)
6.1.6 Halliburton Market 2023-2030 (Volume/Units)
6.1.7 Baker Hughes Incorporated Market 2023-2030 (Volume/Units)
6.1.8 Clariant Chemicals Market 2023-2030 (Volume/Units)
6.1.9 Ecolab Market 2023-2030 (Volume/Units)
6.1.10 GasHydrate LLC Market 2023-2030 (Volume/Units)
7.North America Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Product Type Market 2023-2030 ($M)
7.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
8.North America Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Terrain Type Market 2023-2030 ($M)
8.1 By Terrain Type, Market 2023-2030 ($M) - Regional Industry Research
9.North America Competition Analysis Market 2023-2030 ($M)
9.1 Competition Deep Dive Market 2023-2030 ($M) - Regional Industry Research
9.1.1 BASF SE Market 2023-2030 ($M)
9.1.2 Schlumberger Market 2023-2030 ($M)
9.1.3 Arkema Group Market 2023-2030 ($M)
9.1.4 Ashland Market 2023-2030 ($M)
9.1.5 ERO CHEM LLC Market 2023-2030 ($M)
9.1.6 Halliburton Market 2023-2030 ($M)
9.1.7 Baker Hughes Incorporated Market 2023-2030 ($M)
9.1.8 Clariant Chemicals Market 2023-2030 ($M)
9.1.9 Ecolab Market 2023-2030 ($M)
9.1.10 GasHydrate LLC Market 2023-2030 ($M)
10.South America Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Product Type Market 2023-2030 ($M)
10.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
11.South America Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Terrain Type Market 2023-2030 ($M)
11.1 By Terrain Type, Market 2023-2030 ($M) - Regional Industry Research
12.South America Competition Analysis Market 2023-2030 ($M)
12.1 Competition Deep Dive Market 2023-2030 ($M) - Regional Industry Research
12.1.1 BASF SE Market 2023-2030 ($M)
12.1.2 Schlumberger Market 2023-2030 ($M)
12.1.3 Arkema Group Market 2023-2030 ($M)
12.1.4 Ashland Market 2023-2030 ($M)
12.1.5 ERO CHEM LLC Market 2023-2030 ($M)
12.1.6 Halliburton Market 2023-2030 ($M)
12.1.7 Baker Hughes Incorporated Market 2023-2030 ($M)
12.1.8 Clariant Chemicals Market 2023-2030 ($M)
12.1.9 Ecolab Market 2023-2030 ($M)
12.1.10 GasHydrate LLC Market 2023-2030 ($M)
13.Europe Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Product Type Market 2023-2030 ($M)
13.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
14.Europe Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Terrain Type Market 2023-2030 ($M)
14.1 By Terrain Type, Market 2023-2030 ($M) - Regional Industry Research
15.Europe Competition Analysis Market 2023-2030 ($M)
15.1 Competition Deep Dive Market 2023-2030 ($M) - Regional Industry Research
15.1.1 BASF SE Market 2023-2030 ($M)
15.1.2 Schlumberger Market 2023-2030 ($M)
15.1.3 Arkema Group Market 2023-2030 ($M)
15.1.4 Ashland Market 2023-2030 ($M)
15.1.5 ERO CHEM LLC Market 2023-2030 ($M)
15.1.6 Halliburton Market 2023-2030 ($M)
15.1.7 Baker Hughes Incorporated Market 2023-2030 ($M)
15.1.8 Clariant Chemicals Market 2023-2030 ($M)
15.1.9 Ecolab Market 2023-2030 ($M)
15.1.10 GasHydrate LLC Market 2023-2030 ($M)
16.APAC Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Product Type Market 2023-2030 ($M)
16.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
17.APAC Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Terrain Type Market 2023-2030 ($M)
17.1 By Terrain Type, Market 2023-2030 ($M) - Regional Industry Research
18.APAC Competition Analysis Market 2023-2030 ($M)
18.1 Competition Deep Dive Market 2023-2030 ($M) - Regional Industry Research
18.1.1 BASF SE Market 2023-2030 ($M)
18.1.2 Schlumberger Market 2023-2030 ($M)
18.1.3 Arkema Group Market 2023-2030 ($M)
18.1.4 Ashland Market 2023-2030 ($M)
18.1.5 ERO CHEM LLC Market 2023-2030 ($M)
18.1.6 Halliburton Market 2023-2030 ($M)
18.1.7 Baker Hughes Incorporated Market 2023-2030 ($M)
18.1.8 Clariant Chemicals Market 2023-2030 ($M)
18.1.9 Ecolab Market 2023-2030 ($M)
18.1.10 GasHydrate LLC Market 2023-2030 ($M)
19.MENA Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Product Type Market 2023-2030 ($M)
19.1 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
20.MENA Low Dosage Hydrate Inhibitors Market Analysis and Forecast , by Terrain Type Market 2023-2030 ($M)
20.1 By Terrain Type, Market 2023-2030 ($M) - Regional Industry Research
21.MENA Competition Analysis Market 2023-2030 ($M)
21.1 Competition Deep Dive Market 2023-2030 ($M) - Regional Industry Research
21.1.1 BASF SE Market 2023-2030 ($M)
21.1.2 Schlumberger Market 2023-2030 ($M)
21.1.3 Arkema Group Market 2023-2030 ($M)
21.1.4 Ashland Market 2023-2030 ($M)
21.1.5 ERO CHEM LLC Market 2023-2030 ($M)
21.1.6 Halliburton Market 2023-2030 ($M)
21.1.7 Baker Hughes Incorporated Market 2023-2030 ($M)
21.1.8 Clariant Chemicals Market 2023-2030 ($M)
21.1.9 Ecolab Market 2023-2030 ($M)
21.1.10 GasHydrate LLC Market 2023-2030 ($M)
LIST OF FIGURES
1.US Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)2.Canada Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
3.Mexico Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
4.Brazil Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
5.Argentina Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
6.Peru Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
7.Colombia Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
8.Chile Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
9.Rest of South America Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
10.UK Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
11.Germany Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
12.France Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
13.Italy Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
14.Spain Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
15.Rest of Europe Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
16.China Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
17.India Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
18.Japan Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
19.South Korea Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
20.South Africa Low Dosage Hydrate Inhibitors Market Revenue, 2023-2030 ($M)
21.North America Low Dosage Hydrate Inhibitors By Application
22.South America Low Dosage Hydrate Inhibitors By Application
23.Europe Low Dosage Hydrate Inhibitors By Application
24.APAC Low Dosage Hydrate Inhibitors By Application
25.MENA Low Dosage Hydrate Inhibitors By Application